|
COMMERCE BUSINESS DAILY ISSUE OF OCTOBER 8,1997 PSA#1947National Cancer Institute, Research Contracts Branch, Cancer Etiology
Contracts Section, Executive Plaza South, Rm. 620, 6120 Executive
Blvd., MSC 7224, Bethesda, MD 20892-7224 B -- PROCUREMENT OF DNA, RNA, TRANSFORMED LYMPHOCYTES, AND
LYMPHOBLASTOID LINES FOR GENETIC STUDIES SOL N02-CP-81019-50 DUE 120197
POC Karen L. McFarlane, Contracting Officer, (301) 496-8611 WEB:
National Cancer Institute, http://cbdnet.access.gpo.gov. E-MAIL: Karen
L. McFarlane, Contracting Officer, NCI, km63k@nih.gov. The Genetic
Epidemiology Branch (GEB) of the Divison of Cancer Epidemiology and
Genetics (DCEG) of the National Cancer Institute (NCI) is recompeting
a project which is currently being performed by the American Type
Culture Collection under contract No. NO2-CP-40500. The GEB is seeking
a Contractor who will support the GEB by performing four assays or
procedures. One, two, three, or all four of the procedures will be
performed on each biospecimen. The procedures are: 1) Extraction of DNA
from fresh whole blood specimens, transformed lymphoblastoid lines,
cultured fibroblasts, tumor specimens, buccal cells, paraffin-embedded
tissue, Guthrie cards, or cytology preparations; 2) Extraction of RNA
from fresh whole blood specimens, transformed lymphoblastoid lines,
cultured fibroblasts, tumor specimens, or other biological specimens,
as possible from advances in technology; 3) Isolation of lymphocytes,
and transformation of lymphocytes to lymphoblastoid cells using the
Epstein-Barr virus (EBV); 4) Expansion of lymphoblastoid cell lines up
to gram quantities. Approximately 5200 samples will be submitted to
the Contractor for processing during a one-year period. It is
anticipated that an incrementally funded, cost-reimbursement,
completion type contract will be awarded for a three- year period, with
two one year options. The anticipated RFP date is on or about October
30, 1997, with responses due approximately 30 calendar days after the
actual issuance date. (0279) Loren Data Corp. http://www.ld.com (SYN# 0015 19971008\B-0001.SOL)
B - Special Studies and Analyses - Not R&D Index Page
|
|